# A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction

> **NCT06729671** · NA · RECRUITING · sponsor: **University College Cork** · enrollment: 70 (estimated)

## Conditions studied

- Psychosis

## Interventions

- **DIETARY_SUPPLEMENT:** Bifidobacterium longum APC1472 hydroxypropylmethylcellulose (HPMC) capsule
- **DIETARY_SUPPLEMENT:** maltodextrin

## Key facts

- **NCT ID:** NCT06729671
- **Lead sponsor:** University College Cork
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-16
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06729671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06729671, "A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06729671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*